Editor's Note: In this article, Wu Yanni and Zhou Qing'an, researchers from the Global Development and Health Communication Center at China's Tsinghua University, discuss the new strategies for China's engagement in global health assistance. The article reflects the authors' opinions and not necessarily the views of CGTN.

China's State Council Information Office released a white paper on global governance titled "More Just and Equitable Global Governance: China's Principles, Proposals and Actions" on June 17, 2026. Among its central messages, the white paper calls for the voices of the Global South to be heard more and for the international community to be provided with more public goods. These messages read as timely responses to a crisis already unfolding.

In May, an Ebola outbreak in the Ituri province of the Democratic Republic of the Congo (DRC) spread rapidly into East Africa, hampered by a critical lack of timely detection and contact tracing. Public health analysts have traced this delay back to the disruption of USAID funding, the financial assistance provided by the US government. 

In March 2025, the United States terminated 83% of USAID's global programs, cutting roughly 80% of global health aid projects worth some $12.7 billion. Field epidemiology training and frontline health worker salaries were abruptly cut off in the DRC as a result, and disease surveillance capacity collapsed soon after.

This pattern extends well beyond a single country. The United States cut more than $9 billion in health-related development assistance in 2025 alone, and several major European donors soon followed with cuts of their own. The global health financing system is thus undergoing a systemic contraction.

Against this backdrop, it is tempting to read China's continued engagement in global health as an attempt to step into the breach left by Washington and European capitals. However, China's health-related spending remains far smaller in scale than the gap left by retreating Western donors, and it was never designed to replace that role in the first place.

China's recent health engagement looks less like an attempt to become the next dominant funder and more like an effort to take on a role proportionate to its own capacity within a more distributed system. In Laos, China-supported health cooperation has ranged from child cardiac care programs to schistosomiasis elimination efforts, combining medical services, disease surveillance, and capacity building through development financing. In Africa, building on the infrastructure foundation of the China-supported Africa CDC headquarters, cooperation has expanded into laboratory capacity building, disease surveillance, and workforce training. At this year's World Health Assembly, China joined eight other countries, including Brazil and Ethiopia, to launch a digital health initiative aimed at advancing more equitable and resilient health systems through technology.

These examples suggest that China's global health engagement is not a collection of isolated projects, but rather a more holistic approach that integrates infrastructure, technology transfer, capacity building, and knowledge sharing. Such efforts reflect a broader shift in how global health public goods can be produced in a manner that is more responsive to local contexts and more attentive to the priorities and voices of the Global South. This aligns with the vision outlined in the white paper, which calls for expanding the provision of global public goods while enabling greater participation of Global South countries in shaping global governance. In fact, what the white paper points toward is not simply a changing of the guard.

A useful way to understand this alternative model of global health governance comes from a concept increasingly discussed in the study of global public goods: aggregation technology. Recent research by Chinese scholars Xue Lan and Sun Tianshu applies this framework to global health governance, arguing that the future should move toward an arrangement in which countries and institutions contribute according to their actual capacities, rather than relying on a single dominant power to provide the majority of global health public goods.

Under the conventional aid model, one or a few major donors often design projects, earmark funding, and determine which diseases or interventions receive priority, while recipient countries primarily play an implementing role. The voices of Global South countries are therefore structurally constrained by the financing arrangements themselves. By contrast, under an aggregation model, agenda setting should not be determined solely by who contributes the most financially. Instead, it should be shaped by the diverse capacities, experiences, and knowledge that different countries and institutions bring to the table.

Viewed through this lens, the aggregation model may offer a useful explanation for why a more distributed system of global health cooperation can be more resilient. For decades, much of the traditional global health financing architecture has operated through relatively independent funding streams, including USAID programs, European bilateral aid, and multilateral replenishment mechanisms, whose combined contributions formed the backbone of global health financing. The vulnerability of this model became increasingly visible when several major sources of funding were simultaneously reduced or suspended in 2025. Because the system relied heavily on a limited number of large contributors, these sudden disruptions created significant gaps that were difficult to absorb quickly. By contrast, some of China's global health engagements may offer a different source of resilience, as health cooperation is often embedded within broader development partnerships, including infrastructure, technology, and capacity-building initiatives, rather than relying solely on stand-alone health funding.

The more useful question raised by this moment is not which country will fill the gap left by another. It is what kind of supply structure can support both resilience and a more genuine redistribution of agenda-setting power. The white paper's emphasis on providing more public goods and listening more closely to the Global South points toward this underlying shift: a transition toward a global health system organized less around who can write the biggest check and more around a deliberate weighting of capacity, knowledge, and need across many contributors.